Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/12/2011EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011EP2374452A1 Nutrient composition
10/12/2011EP2374451A2 Histone deacetylase inhibitors (HDAC) that correct protein misfolding and uses thereof
10/12/2011EP2374450A1 Flupentixol compositions
10/12/2011EP2374449A2 Composition including at least one aqueous phase and at least one oil phase including ivermectin
10/12/2011EP2374448A1 Oral film formulation
10/12/2011EP2374006A1 Methods and reagents for diagnosing atheroma
10/12/2011EP2373998A1 Nitroprotein biomarkers for copd
10/12/2011EP2373993A2 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human
10/12/2011EP2373794A1 Nectin-4 for target genes of cancer therapy and diagnosis
10/12/2011EP2373674A1 2-(n-substituted piperazinyl) steroid derivatives
10/12/2011EP2373673A1 Tgr5 modulators and methods of use thereof
10/12/2011EP2373671A1 Uracyl cyclopropyl nucleotides
10/12/2011EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic
10/12/2011EP2373664A1 Bicyclic pyrazoles as protein kinase inhibitors
10/12/2011EP2373663A1 Thienopyridines as pharmacologically active agents
10/12/2011EP2373662A2 Thieno[3,2-c]pyridine derivatives as kinase inhibitors for use in the treatment of cancer
10/12/2011EP2373659A1 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/12/2011EP2373658A2 Stat3 inhibitors and therapeutic methods using the same
10/12/2011EP2373657A1 5, 7-dihydro- 6h-pyrimido ý 5, 4-d¨ý 1¨benzazepin-6-thiones as plk inhibitors
10/12/2011EP2373656A1 Cinnamido-pvrrolor[2,1-c][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
10/12/2011EP2373655A1 Crystalline forms
10/12/2011EP2373653A1 Pyrrolopyrazinyl urea kinase inhibitors
10/12/2011EP2373652A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
10/12/2011EP2373651A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
10/12/2011EP2373650A1 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
10/12/2011EP2373649A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
10/12/2011EP2373647A1 Pyridazinone derivatives
10/12/2011EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011EP2373644A1 Pyridazinone derivatives
10/12/2011EP2373641A1 Pyridazinone derivatives
10/12/2011EP2373640A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
10/12/2011EP2373639A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
10/12/2011EP2373636A1 Inhibitors of phosphoinositide dependent kinase 1 (pdk1)
10/12/2011EP2373635A1 Benzothiazolone derivative
10/12/2011EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011EP2373632A1 Substituted benzyl and phenylsulfonyl triazolones, and use thereof
10/12/2011EP2373631A2 Antibacterial compounds
10/12/2011EP2373630A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
10/12/2011EP2373629A1 Compounds for treating cancer
10/12/2011EP2373628A1 Novel compounds
10/12/2011EP2373627A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
10/12/2011EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011EP2373624A1 Transition metal complexes of a bisýthiohydrazide amide¨compound
10/12/2011EP2373618A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
10/12/2011EP2373610A1 Plant extracts from acronychia species and their use
10/12/2011EP2373605A1 Compounds for use in the treatment of pain
10/12/2011EP2373344A1 Combined drug administration
10/12/2011EP2373343A1 Immunocytokines for tumour therapy with chemotherapeutic agents
10/12/2011EP2373342A1 Method for inducing a trif-bias
10/12/2011EP2373329A2 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/12/2011EP2373326A1 Crystalline forms of genistein
10/12/2011EP2373319A2 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
10/12/2011EP2373318A1 Imidazopyrazine syk inhibitors
10/12/2011EP2373317A1 Soluble guanylate cyclase activators
10/12/2011EP2373316A1 Treatment for glomerulonephritis with 2 - ý 4- ( -7-ethyl-5h-pyrrolo ý 2,3-b¨-pyrazin- 6 -yl) propan-2-ol
10/12/2011EP2373315A2 Methods and compositions related to targeting monoacylglycerol lipase
10/12/2011EP2373314A1 Use of eltoprazine for the treatment of l-dopa-induced dyskinesia
10/12/2011EP2373313A1 Substituted pyrazole compounds
10/12/2011EP2373312A1 A composition for use on skin and wound
10/12/2011EP2373311A1 Inhibitors of hif-1 protein accumulation
10/12/2011EP2373310A1 Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
10/12/2011EP2373309A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide
10/12/2011EP2373308A2 Combination therapy for the treatment of cancer
10/12/2011EP2373307A1 Novel use of fibrates
10/12/2011EP2373306A1 Transdermally administered aliskiren
10/12/2011EP2373305A1 Transdermal pharmaceutical compositions comprising a serm
10/12/2011EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011EP2373303A1 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
10/12/2011EP2373302A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
10/12/2011EP2373297A1 Tamsulosin pellets for fixed dose combination
10/12/2011EP2373295A2 Steroidal compositions
10/12/2011EP2373289A2 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
10/12/2011EP2373288A2 A novel dermaceutical cream made using sodium fusidate
10/12/2011EP2373172A1 Inhibitors of hcv ns5a
10/12/2011EP2373171A1 Frequency modulated drug delivery (fmdd)
10/12/2011EP2373169A1 Imidazopyrazine syk inhibitors
10/12/2011EP2373168A1 Inhibitors of hcv ns5a
10/12/2011EP2373167A1 Inhibitors of hcv ns5a
10/12/2011EP2373166A2 Antimicrobial compositions
10/12/2011EP2373165A1 Substituted dioxopiperidinyl phthalimide derivaties
10/12/2011EP2373161A1 Methods for increasing endogenous plasmalogen levels
10/12/2011EP2373160A1 Topically active steroids for use in radiation and chemotherapeutics injury
10/12/2011EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
10/12/2011EP2227455B1 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
10/12/2011EP2176253B1 A process for the preparation or purification of olmesartan medoxomil or olmesartan medoxomil hydrohalide salt
10/12/2011EP2168964B1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
10/12/2011EP2114408B1 Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
10/12/2011EP2107052B1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/12/2011EP2094683B1 Bicyclic compounds and use as antidiabetics
10/12/2011EP2077846B1 Benzoxazepine compounds, their preparation and use
10/12/2011EP2064189B1 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
10/12/2011EP2023937B1 Rnai modulation of aha and therapeutic uses thereof
10/12/2011EP2023926B1 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
10/12/2011EP2019680B1 Augmentation of titer for vaccination in animals
10/12/2011EP2004173B1 Use of aminapthone for the preparation of a medicament for treating arteriophaties
10/12/2011EP2001878B1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
10/12/2011EP1928892B1 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
10/12/2011EP1919906B1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
1 ... 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 ... 7860